JP2010540627A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540627A5
JP2010540627A5 JP2010527928A JP2010527928A JP2010540627A5 JP 2010540627 A5 JP2010540627 A5 JP 2010540627A5 JP 2010527928 A JP2010527928 A JP 2010527928A JP 2010527928 A JP2010527928 A JP 2010527928A JP 2010540627 A5 JP2010540627 A5 JP 2010540627A5
Authority
JP
Japan
Prior art keywords
composition
radioisotope
tissue mass
amount
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010527928A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010540627A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/002026 external-priority patent/WO2009045230A1/en
Publication of JP2010540627A publication Critical patent/JP2010540627A/ja
Publication of JP2010540627A5 publication Critical patent/JP2010540627A5/ja
Pending legal-status Critical Current

Links

JP2010527928A 2007-10-05 2008-02-15 放射性同位体の直接投与による腫瘍治療のための組成物 Pending JP2010540627A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99785607P 2007-10-05 2007-10-05
US99787307P 2007-10-05 2007-10-05
PCT/US2008/002026 WO2009045230A1 (en) 2007-10-05 2008-02-15 Compositions for treatment of tumors by direct administration of a radioisotope

Publications (2)

Publication Number Publication Date
JP2010540627A JP2010540627A (ja) 2010-12-24
JP2010540627A5 true JP2010540627A5 (enExample) 2011-04-07

Family

ID=40526495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010527928A Pending JP2010540627A (ja) 2007-10-05 2008-02-15 放射性同位体の直接投与による腫瘍治療のための組成物

Country Status (4)

Country Link
EP (1) EP2195036A4 (enExample)
JP (1) JP2010540627A (enExample)
CA (1) CA2701537A1 (enExample)
WO (1) WO2009045230A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
DOP2010000279A (es) * 2009-09-18 2012-06-15 Sari Asher Llc Composiciones radiofarmaceuticas no-coloidales sin sellar y metodos para el tratamiento de tejido anormal
WO2011152909A2 (en) * 2010-03-09 2011-12-08 Kurion, Inc. Isotope-specific separation and vitrification using ion-specific media
GB2490317A (en) 2011-04-19 2012-10-31 Dspi Ltd Radioactive solution undergoing in situ precipitation at a tumour site for cancer therapy
KR102006599B1 (ko) * 2011-12-21 2019-08-01 아이소테라퓨틱스 그룹 엘엘씨 방사성 조성물 및 그의 치료적 사용 방법
WO2013191781A2 (en) 2012-03-26 2013-12-27 Kurion, Inc. Selective regeneration of isotope-specific media resins in systems for separation of radioactive isotopes from liquid waste materials

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849209A (en) * 1985-06-07 1989-07-18 Cadema Medical Products, Inc. Treatment of arthritis, including rheumatoid arthritis with 166 Holmium radionuclide
US4915932A (en) * 1987-10-14 1990-04-10 Australian Nuclear Science & Technology Organisation Macroaggregates for radiation synovectomy
EP1610751A4 (en) * 2001-04-26 2006-05-24 Univ Texas THERAPEUTIC AGENT / LIGAND CONJUGATE COMPOSITIONS, ITS SYNTHESIS PROCESSES AND ITS APPLICATION
WO2004050168A2 (en) * 2002-11-27 2004-06-17 Board Of Regents, The University Of Texas System Radiopharmaceuticals and radioactive microspheres for locoregional ablation of abnormal tissues
US8388955B2 (en) * 2003-03-03 2013-03-05 Xencor, Inc. Fc variants
WO2007008232A2 (en) * 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
AU2005290229A1 (en) * 2004-09-24 2006-04-06 Biosphere Medical, Inc. Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2010540627A5 (enExample)
JP7059372B2 (ja) デュアルモードの放射性トレーサーおよび療法剤
JP3535154B2 (ja) 関節炎の処理のための放射性ラベルされた金属結合性タンパク質
JP2025100545A (ja) 鉛またはトリウム放射性核種に連結されたｐｓｍａ標的化化合物を含む錯体
Kiess et al. Prostate-specific membrane antigen as a target for cancer imaging and therapy
Ogawa et al. Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals
HRP20240952T1 (hr) Spojevi koji ciljaju psma i njihova uporaba
US5300281A (en) Radiolabeled compositions containing a calcific matrix and their use for treatment of arthritis
WO2008043911A3 (fr) Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant
Ogawa et al. Well‐Designed Bone‐Seeking Radiolabeled Compounds for Diagnosis and Therapy of Bone Metastases
JP2007297404A (ja) 腫瘍造影剤としてのヌクレオチドポリリン酸に結合された放射性核種
JP2010516679A5 (enExample)
CN118785925A (zh) 用于核医学治疗诊断的具有三个或更多个靶向载体的标志物前体和放射性示踪剂
Ogawa et al. Preparation and evaluation of a radiogallium complex-conjugated bisphosphonate as a bone scintigraphy agent
Walther et al. Synthesis and biological evaluation of a new type of 99mTechnetium-labeled fatty acid for myocardial metabolism imaging
JP7771080B2 (ja) 医薬配合物
El-Mabhouh et al. 188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases
CA2701537A1 (en) Compositions for treatment of tumors by direct administration of a radioisotope
US20250288703A1 (en) Alpha Emitter Compositions And Methods
JP4469133B2 (ja) ビオチン誘導体およびキレート化剤とのその複合体
JP2018515585A (ja) 放射性同位体用ｄｏｔｍｐキット製剤
Panwar et al. Synthesis of trans-1, 2-cyclohexyldinitrilo tetramethylene phosphonic acid and its radiolabelling with 99mTc for the detection of skeletal metastases
WO2005011738A3 (en) Polymeric conjugates containing phosphine - based chelating groups
Martin et al. Bifunctional chelating agents for targeted {alpha}-particle radiotherapy
HK40113686A (zh) 用於核医学治疗诊断的具有三个或更多个靶向载体的标志物前体和放射性示踪剂